04 October 2022 : Original article
Incidence of COVID-19 and Identification of Possible Risk Factors Associated with COVID-19 in Acute Renal Transplant Recipients in Pakistan
Nida SaleemDOI: 10.12659/AOT.937688
Ann Transplant 2022; 27:e937688
Table 1 Pre and post-transplant characteristics of kidney transplant recipients.
| Pre-transplant characteristics | Post-transplant characteristics | ||||
|---|---|---|---|---|---|
| 12±5 SD | |||||
| ATGe | 29/50 | 58% | |||
| Basiliximab | 14/50 | 28% | |||
| None | 7/50 | 14% | |||
| 35.38±11.690 SD | |||||
| <7 days | 32/50 | 64% | |||
| ≥7 days | 18/50 | 36% | |||
| 1.20±0.41 SD | |||||
| Male | 41/50 | 82% | |||
| Female | 9/50 | 18% | |||
| a | 23.673±4.5685 SD | f | 11/50 | 22% | |
| 12/50 | 24% | ||||
| Diabetes mellitus | 19/50 | 38% | |||
| Hypertension | 46/50 | 92% | |||
| Hepatitis B | 6/50 | 12% | |||
| Hepatitis C | 9/50 | 18% | |||
| Stroke | 3/50 | 6% | |||
| History of smoking | 12/50 | 24% | |||
| 4/50 | 8% | ||||
| ATNg | 8/12 | 66.6% | |||
| Rejection | 3/12 | 25% | |||
| Others | 1/12 | 8.33% | |||
| b | 18/50 | 36% | |||
| Diabetic Nephropathy | 9/50 | 18% | |||
| Hypertensive Nephropathy | 10/50 | 20% | |||
| Reflux Nephropathy | 5/50 | 10% | |||
| IgA Nephropathy | 7/50 | 14% | |||
| FSGSc | 5/50 | 10% | |||
| Other Glomerulonephritis | 3/50 | 6% | |||
| Obstructive Nephropathy | 8/50 | 16% | |||
| Others | 2/50 | 4% | |||
| Pre-emptive transplant | 8/50 | 16% | |||
| <6 months | 22/50 | 44% | <10 | 13/50 | 26% |
| 7–12months | 7/50 | 14% | >10 | 37/50 | 74% |
| >1 year | 13/50 | 26% | |||
| d | |||||
| 0 | 9/50 | 18% | Face to face | 21/50 | 42% |
| 1–5 | 28/50 | 56% | Telemedicine and face to face | 29/50 | 58% |
| >5 | 13/50 | 26% | |||
| a – Body mass index b – end stage renal disease c – focal segmental glomerulosclerosis d – Human leukocyte antigens e – anti-thymocyte globulin F – new onset diabetes after transplant g – acute tubular necrosis. | |||||






